目的 研究经外周中心静脉置管(PICC)和经锁骨下静脉完全植入式输液港(TIVAP)两种不同方法在肿瘤患者化疗中应用的优缺点.方法 回顾性分析2016年3月至2016年12月160例采用PICC(80例)和TIVAP(80例)两种途径中心静脉置管肿瘤患者的临床资料,并对两组患者的并发症进行比较、分析.结果 TIVAP组导管阻塞率、导管感染发生率和静脉炎发生率均低于PICC组(P<0.05).结论 TIVAP并发症低,留置时间延长,并且对患者带管期间的生活质量影响较小.%Objective To study the advantages and disadvantages of two methods(the peripherally inserted central venous catheter (PICC) and the totally implantable venous-access ports (TIVAP) in the chemotherapy of tumor patients. Methods The clinical data of 160 patients treated with PICC or TIVAP from March 2016 to December 2016 were retrospectively reviewed,and the complications of the two groups were compared and reviewed. Results The catheter occlusion rate,catheter infection rate and the incidence of phlebitis in the TIVAP group were lower than that in the PICC group (P<0.05). Conclusions The patents treated with TIVAP have fewer complications and prolonged indwelling time has no impact on the life quality of patients.
展开▼
